Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes. Cannon CP, Pratley R, Dagogo-Jack S, Mancuso J, et al. N Engl J Med 2020 Sep 23. doi: 10.1056/NEJMoa2004967.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cannon CP, Pratley R, Dagogo-Jack S, Mancuso J, et al. Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes. N Engl J Med 2020 Sep 23. doi: 10.1056/NEJMoa2004967.
PMID: 32966714